BioSpace News Archive

Fixed-dose combination is administered under the skin in just minutes, compared to hours with intravenous administration, significantly reducing time spent receiving treatment

Lysogene announced that the U.S. Food and Drug Administration has granted Fast Track Designation to its LYS-SAF302 program for the treatment of mucopolysaccharidosis Type IIIA.

PRINCETON, N.J., Feb. 25, 2020 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a forward-thinking women’s healthcare company, today announced that the Company will visit the Nasdaq MarketSite in Times Square on Wednesday, February 26, 2020. In honor of the occasion, Agile Therapeutics Chairman & CEO Al Altomari will ring the Closing Bell. Where : Nasdaq MarketSite – 4 Times Square – 43 rd & Broadway – Broadcast Studio When : Wednesday, February 26, 2020 – 3:45 p.m.

MedeAnalytics, a healthcare analytics software-as-a-service (SaaS) leader, announced today that the administrative measure logic in its Quality Management product has achieved 2020 National Committee for Quality Assurance (NCQA) certification for the Healthcare Effectiveness Data and Information Set (HEDIS®) measures for the seventh consecutive year.

Today, Levadura Biotechnology Inc., a leader in synthetic biology with a unique feedstock and biocatalysis approach, announced that it has received the International Search Report (ISR) for Levadura’s first Patent Cooperation Treaty (PCT) patent application.

Feb. 25, 2020 16:38 UTC Nine rising startup companies from Utah’s growing life sciences industry will present their innovations to investors during the 2020 Entrepreneur & Investor Life Science Summit on February 28, sponsored by Simpson Thacher SALT LAKE CITY--( BUSINESS WIRE )-- BioUtah, Utah’s only trade association dedicated solely to the life sciences, in partnership with the University of Utah’s Center for Technology & Venture Commercialization (TVC), today an

Cardiac Dimensions, a leader in the development of innovative, minimally invasive treatments for functional mitral regurgitation (FMR) in patients with heart failure (HF), today announced the findings of a post hoc analysis of pooled prospectively collected data from three studies of the Carillon Mitral Contour System® with a focus on 5-year survival rate and the determinants of long-term survival.

AIVITA Biomedical, Inc., a biotechnology company (the “Company”) specializing in innovative stem cell applications, announced today the first closing of its $25 million Series B-2 preferred stock investment round.

PTCE, a leader in continuing education for retail, health-system, oncology, managed care and specialty pharmacists, will conduct three continuing education satellite symposia at the American Pharmacists Association (APhA) 2020 Annual Meeting & Exposition on March 21 and 22 at the Gaylord National Resort & Conference Center in National Harbor, Maryland.

Stryker (NYSE:SYK) ) will participate in the Cowen 40th Annual Health Care Conference on Tuesday, March 3, 2020 at the Boston Marriott Copley Place in Boston, Massachusetts.